A Translational Understanding of Obesity-Related Phenotypes Using Brain Imaging and Manipulation (OPBIM)

April 2, 2024 updated by: Drexel University
This study will examine a potential relationship between family history of obesity, that is whether people with at least one parent who had obesity in adulthood compared to people with two parents who did not have obesity in adulthood, and the ability of protein intake to curb further intake of food.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

1) Abstract of the study A positive energy balance (greater intake than expenditure) can explain weight gain and, when protracted, leads to overweight and obesity. The major question addressed in this proposal is if the timing of activation of specific regions of the brain is predictive of excessive food intake. Functional near infra-red spectroscopy (fNIR), seldom used in human eating studies, provides data similar to functional magnetic resonance imaging (fMRI) but allows for measurement of brain activation during food consumption. The investigator's pilot fNIR data reveal that varying patterns of regional PFC activation are associated with "loss of control" over eating, and that only 60% of individuals respond to acute protein intake with a reduction in food intake. Using fNIR and an acute protein challenge, the investigator will assess the effect of family history of obesity in humans on the satiation response to protein and concomitant activation of the prefrontal cortex (PFC). It is hypothesized that activation of the human medial PFC before the lateral PFC will result in greater intake of palatable food in those subjects with a proneness to obesity, and that these subjects will be less sensitive to the satiety-inducing effects of a protein preload. These results should provide an innovative and useful method for assessing risk for developing obesity and usefulness of preventative interventions.

Study Type

Interventional

Enrollment (Estimated)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Pennsylvania
      • Philadelphia, Pennsylvania, United States, 19104

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria

  • BMI 20-40
  • weight stable for at least 3 months
  • no parents with history of obesity in adulthood, or at least one parent with history of obesity in adulthood

Exclusion Criteria

  • no current diagnosis of psychiatric disorders
  • no current diagnosis of neurological disorders
  • no current diagnosis or history of anorexia nervosa
  • no current diagnosis or history of bulimia nervosa
  • no pregnancy within the last 9 months
  • not currently breastfeeding
  • no use of investigational medication in the past 6 months
  • no use of prescription anti-seizure medications.
  • no use of prescription antidepressant medications
  • no use of prescription antipsychotic medications

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Preloads
Delivery of two different preloads to all participants, each preload tested on a separate day/participant, prior to consumption of pizza
Ensure, a liquid meal with 9 grams of protein in 8 ounces consumed 20 minutes before eating pizza; and water, 8 ounces consumed 20 minutes before eating pizza

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Grams of pizza consumed
Time Frame: 3-15 minutes
Ad libitum during the pizza eating episode
3-15 minutes
Baseline medial prefrontal cortex oxygenated hemoglobin
Time Frame: 20 minutes
Micromoles per millimeter of oxygenated hemoglobin of the medial prefrontal cortex prior to pizza consumption
20 minutes
Baseline lateral prefrontal cortex oxygenated hemoglobin
Time Frame: 20 minutes
Micromoles per millimeter of oxygenated hemoglobin of the lateral prefrontal cortex prior to pizza consumption
20 minutes
medial prefrontal cortex Oxygenated hemoglobin concentration
Time Frame: 3-15 minutes
Micromoles per millimeter of oxygenated hemoglobin of the medial prefrontal cortex during pizza consumption phase
3-15 minutes
lateral prefrontal cortex Oxygenated hemoglobin concentration
Time Frame: 3-15 minutes
Micromoles per millimeter of oxygenated hemoglobin of the lateral prefrontal cortex during pizza consumption phase
3-15 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
medial prefrontal cortex Time to Peak Light Intensity
Time Frame: 3-15 minutes
The time in seconds that it takes for the oxygenated hemoglobin signal to reach peak in the medial prefrontal cortex during the ad libitum eating episode for each preload
3-15 minutes
lateral prefrontal cortex Time to Peak Light Intensity
Time Frame: 3-15 minutes
The time in seconds that it takes for the oxygenated hemoglobin signal to reach peak in the lateral prefrontal cortex during the ad libitum eating episode for each preload
3-15 minutes
Preload Oxygenated Hemoglobin Difference
Time Frame: 5 minutes
The difference between the oxygenated hemoglobin concentrations obtained under the two different preloads
5 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 4, 2023

Primary Completion (Estimated)

September 1, 2025

Study Completion (Estimated)

September 1, 2025

Study Registration Dates

First Submitted

February 15, 2024

First Submitted That Met QC Criteria

April 2, 2024

First Posted (Actual)

April 9, 2024

Study Record Updates

Last Update Posted (Actual)

April 9, 2024

Last Update Submitted That Met QC Criteria

April 2, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 2306009984

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on Ensure and Water

Subscribe